Comparison of QIPB and SIFICB in Hip Surgery
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Quadro-İliac Plane Block(QİPB), Suprainguinal Fascia Iliaca Compartiment Block.
- Who it may be relevant to
- Registry conditions: Postoperative Pain, Hip Surgery. Basic parameters: 18 years — 99 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Comparison of the Effects of Quadroiliac Plane Block Versus Suprainguinal Fascia Iliaca Compartment Block on Postoperative Pain in Hip Surgery
Overview
The aim is to compare the postoperative analgesic effects of Quadroiliac Plane Block (QIPB) and Suprainguinal Fascia Iliaca Compartment Block (SIFICB) in patients undergoing hip surgery.
Detailed description
Patients were divided into two randomized groups: Group 1 (QIPB group, n=30) and Group 2 (SIFICB group, n=30). All patients will receive the same standard general anesthesia per hospital protocol. All blocks will be applied with the same ultrasonography and block equipment, and by the same physician. After the anesthesia induction, patients in Group 1 will receive Quadroiliac Plane Block (QIPB) with 40 mL of 0.25% bupivacaine. Patients in Group 2 will receive Suprainguinal Fascia Iliaca Compartment Block (SIFICB) with 30 mL of 0.25% bupivacaine. All patients will receive Paracetamol 1gr and Dexketoprofen 50mg intravenous (IV) 10 minutes prior to skin closure. Routine analgesic procedure consisting of 3x400mg Ibuprofen will be followed postoperatively for 24 hours. Numeric Rating Scale (NRS) will be used to assess postoperative pain on 1st, 6th, 12th, 18th and 24th hours after the surgery. Tramadol 1mg/kg IV will be administered as a rescue analgesic for all patients if NRS score is higher than 4. Total Tramadol consumption will be calculated.
Interventions
- Procedure Quadro-İliac Plane Block(QİPB)
40 mL of 0.25% bupivacaine - Procedure Suprainguinal Fascia Iliaca Compartiment Block
30 mL of 0.25% bupivacaine
Primary outcome measures
- Numeric Rating Scale (NRS) Scores [Time frame: Postoperative 24 hours]
Secondary outcome measures (1)
- Total tramadol consumption [Time frame: Postoperative 24 hours]
Eligibility criteria
Inclusion criteria
- Adult patients over 18 years of age who underwent percutaneous nephrolithotomy under general anesthesia and were I-II-III according to the American Society of Anesthesiologists (ASA) risk classification were included in the study.
Exclusion criteria
- patients who did not give consent,
- patients with coagulopathy,
- patients with signs of infection at the block application site,
- patients using anticoagulants,
- patients with known allergies to any of the study drugs,
- patients with unstable hemodynamics,
- patients who could not cooperate during postoperative pain assessment
- patients who wanted to withdraw from the study,
- patients with alcohol and drug addiction,
- patients with musculoskeletal abnormalitie
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Quadruple blind
- Primary purpose
- Other
Study locations
Turkey (Türkiye) · 1 center
- Sivas Cumhuriyet University School of Medicine, Anesthesiology and Reanimation — Sivas
Identifiers
NCT: NCT07233746 · 2025-07/23